Philip Bedford

A live, attenuated recombinant West Nile virus vaccine

Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan et al. · Proceedings of the National Academy of Sciences · 2006 · 226 citations · Full text

Vaccination, Molecular Virology, Vaccine Development +12

Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

Thomas P. Monath, Karen McCarthy, Philip Bedford et al. · Vaccine · 2002 · 217 citations

Vaccination, Vaccine Development, Vaccine Research +7

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Thomas P. Monath, Farshad Guirakhoo, Richard Nichols et al. · The Journal of Infectious Diseases · 2003 · 216 citations

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison et al. · Human Vaccines · 2006 · 191 citations · Full text

Phase 2 Clinical Trial of Attenuated<i>Salmonella enterica</i>Serovar Typhi Oral Live Vector Vaccine CVD 908-<i>htrA</i>in U.S. Volunteers

Carol O. Tacket, Marcelo B. Sztein, Steven S. Wasserman et al. · Infection and Immunity · 2000 · 181 citations · Full text